Russian COVID-19 vaccine developer ready to submit project for clinical trials on children
Head of the Gamaleya Research Center for Epidemiology and Microbiology Alexander Ginzburg noted that the trials among children would likely to be split in three groups depending on the age
MOSCOW, December 25. /TASS/. One of the developers of Russia’s COVID-19 vaccine Sputnik V is ready to submit a draft research project on holding clinical trials of the vaccine among children to the Russian Health Ministry. This can happen in a month, after the ministry analyzes the outcomes of the trials held among the elderly, head of the Gamaleya Research Center for Epidemiology and Microbiology Alexander Ginzburg told TASS.